Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like AstraZeneca PLC Jumps Deeper Into mRNA Drugs With Ethris Deal August 20, 2017 Akers Biosciences Announces A $2 Million Private Placement March 30, 2017 GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected February 6, 2017
